HANSA BIOPHARMA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.62 SEK | +5.22% |
|
+5.81% | +16.87% |
| 04-18 | Transcript : Hansa Biopharma AB, Q1 2024 Earnings Call, Apr 18, 2024 | |
| 04-18 | Hansa Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 32.20 | 38.84 | 52.95 |
| Spread/Res. | -4.91% | -21.16% | -42.17% |
| Spread/Supp. | +12.57% | +33.60% | +45.81% |
| Support | 27.20 | 22.92 | 21.00 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- HNSA Stock
- Charts Hansa Biopharma AB
